Improved Market Access Attracts Global Pharmaceutical...
China News
August 6, 2024
The recent policy relaxation in China has significantly shortened the product-to-market cycle for pharmaceutical firms, enabling faster market entry – reducing the timeframe from five years to three years. This move is part of China's broader strategy to attract global pharmaceutical companies. The just-concluded Third Plenary Session underscored China's commitment to further relax market access in the medical industry, reflecting its determination to become a global hub.